YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs.  The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.

Articles Of Association

Announcements and Notices - [Results of EGM/SGM / Continuing Connected Transaction / Amendment of Constitutional Documents]

Poll Results Of
2024 First Extraordinary General Meeting
Held On 31 October 2024

Document On Display

Form Of Proxy For The 2024 First Extraordinary General Meeting To Be Held On Thursday, 31 October 2024

Announcements and Notices - [Notice of EGM/SGM / Closure of Books or Change of Book Closure Period]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Yichang HEC Changjiang Pharma (1558 HK)

Articles Of Association

Poll Results Of 2024 First Extraordinary General Meeting Held On 31 October 2024

Document On Display

Form Of Proxy For The 2024 First Extraordinary General Meeting To Be Held On Thursday, 31 October 2024

Notice Of 2024 First Extraordinary General Meeting

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)